Jump to:Page Content
Stand out from the crowd! Advertise in Trial to reach a national audience of major decision-makers who are looking for products and services to improve their legal practices.
Alyssa E. Lambert
The Supreme Court heard oral arguments on Tuesday in a case that could change how generic drug manufacturers can be held liable to injured consumers. The justices considered whether federal law preempts state products liability claims that allege a generic drug was unreasonably dangerous and defective, and they wavered between recognizing that the decision could be limited to the facts of the case and issuing a broad ruling that could significantly affect both generic and brand-name drug companies.